All Relations between Multiple Sclerosis and ci

Publication Sentence Publish Date Extraction Date Species
Santosh A Helekar, Jae C Shin, Brandi J Mattson, Krystle Bartley, Milena Stosic, Toni Saldana-King, P Read Montague, George J Hutto. Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis. Frontiers in human neuroscience. vol 4. 2011-07-14. PMID:21152340. in multiple sclerosis (ms) functional changes in connectivity due to cortical reorganization could lead to cognitive impairment (ci), or reflect a re-adjustment to reduce the clinical effects of widespread tissue damage. 2011-07-14 2023-08-12 Not clear
Mathilde Deloire, Aurélie Ruet, Delphine Hamel, Melissa Bonnet, Bruno Broche. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Multiple sclerosis (Houndmills, Basingstoke, England). vol 16. issue 5. 2010-08-20. PMID:20194578. forty-five patients, recruited after ms diagnosis, were followed for 7 years by yearly expanded disability status scale (edss) and multiple sclerosis functional composite (msfc) evaluations and were classified as cognitively impaired (ci) or unimpaired (cu) according to neuropsychological testing at baseline. 2010-08-20 2023-08-12 Not clear
Eli Somer, Daniel Golan, Sara Dishon, Limor Cuzin-Disegni, Idit Lavi, Ariel Mille. Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse. Multiple sclerosis (Houndmills, Basingstoke, England). vol 16. issue 4. 2010-07-09. PMID:20086022. 'direct coping and planning' was negatively related to exacerbation of multiple sclerosis symptoms (or = 0.1, 95% ci = 0.02-0.5). 2010-07-09 2023-08-12 human
Benedetta Goretti, Emilio Portaccio, Valentina Zipoli, Bahia Hakiki, Gianfranco Siracusa, Sandro Sorbi, Maria Pia Amat. Impact of cognitive impairment on coping strategies in multiple sclerosis. Clinical neurology and neurosurgery. vol 112. issue 2. 2010-04-23. PMID:19969413. to assess the impact of cognitive impairment (ci) on coping strategies in multiple sclerosis (ms). 2010-04-23 2023-08-12 Not clear
Valentina Zipoli, Benedetta Goretti, Bahia Hakiki, Gianfranco Siracusa, Sandro Sorbi, Emilio Portaccio, Maria Pia Amat. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Multiple sclerosis (Houndmills, Basingstoke, England). vol 16. issue 1. 2010-03-08. PMID:19995837. in the cox regression model, the failure of at least three tests (hr 3.3; 95% ci 1.4-8.1; p = 0.003) and the presence of mcdonald's dissemination in space at baseline (hr 3.8; 95% ci 1.5-9.7; p = 0.005), were found to be predictors for conversion to multiple sclerosis. 2010-03-08 2023-08-12 human
Chris Wallace, Deborah J Smyth, Meeta Maisuria-Armer, Neil M Walker, John A Todd, David G Clayto. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nature genetics. vol 42. issue 1. 2010-02-12. PMID:19966805. the highest association was at marker rs2304256 (odds ratio (or) = 0.86; 95%ci = 0.82-0.90) in the tyk2 gene, which has previously been associated with systemic lupus erythematosus and multiple sclerosis. 2010-02-12 2023-08-12 human
Emilio Portaccio, Benedetta Goretti, Valentina Zipoli, Benedetta Nacmias, Maria Laura Stromillo, Maria Letizia Bartolozzi, Gianfranco Siracusa, Leonello Guidi, Antonio Federico, Sandro Sorbi, Nicola De Stefano, Maria Pia Amat. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 15. issue 12. 2010-02-04. PMID:19965518. the objective of this article was to assess the association between apolipoprotein e (apoe)-epsilon4 and cognitive impairment (ci) in relapsing-remitting multiple sclerosis (rrms). 2010-02-04 2023-08-12 Not clear
Jennifer Massa, E O'Reilly, K L Munger, G N Delorenze, A Ascheri. Serum uric acid and risk of multiple sclerosis. Journal of neurology. vol 256. issue 10. 2010-01-05. PMID:19468784. in analyses including only cases in the nurses' cohorts where blood was collected shortly before onset, there was a trend toward a lower risk of multiple sclerosis among individuals with higher serum urate, but the association was not significant (multivariable relative risk 0.52, 95% ci 0.22, 1.20, p value 0.13). 2010-01-05 2023-08-12 Not clear
Philippe Cabr. Environmental changes and epidemiology of multiple sclerosis in the French West Indies. Journal of the neurological sciences. vol 286. issue 1-2. 2009-12-17. PMID:19520388. multiple sclerosis (ms) emerged in the french west indies (martinique and guadeloupe) at the beginning of the 1990s with an incidence for the period 1992-2007 of 1.27/100,000 (95% ci, 1.16-1.38). 2009-12-17 2023-08-12 Not clear
V W Mark, E Taub, K Bashir, G Uswatte, A Delgado, M H Bowman, C C Bryson, S McKay, G R Cutte. Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings. Multiple sclerosis (Houndmills, Basingstoke, England). vol 14. issue 7. 2008-10-24. PMID:18573826. to evaluate whether constraint-induced movement therapy (ci therapy) may benefit chronic upper extremity hemiparesis in progressive multiple sclerosis (ms). 2008-10-24 2023-08-12 Not clear
H Thuy-Tien, M Haugen, J Aarseth, A Storstein, C A Vedele. Proteasome antibodies in patients with cancer or multiple sclerosis. Scandinavian journal of immunology. vol 67. issue 4. 2008-05-13. PMID:18266796. significant higher odds ratios compared to the blood donors were found for the patients with ovarian cancer (or: 6.4; 95% ci: 1.1-68) and multiple sclerosis (or: 7.1; 95% ci: 1.2-74). 2008-05-13 2023-08-12 Not clear
Zsolt Illes, Eniko Safrany, Agnes Peterfalvi, Lili Magyari, Bernadett Farago, Eva Pozsonyi, Csilla Rozsa, Samuel Komoly, Bela Meleg. 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neuroscience letters. vol 431. issue 1. 2008-05-01. PMID:18180107. multiple regression analysis revealed that presence of aa genotype provides a two-fold risk for the development of multiple sclerosis (or=2.072, 95% ci: 0.988-4.347, p<0.05). 2008-05-01 2023-08-12 human
L K Fisniku, P A Brex, D R Altmann, K A Miszkiel, C E Benton, R Lanyon, A J Thompson, D H Mille. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain : a journal of neurology. vol 131. issue Pt 3. 2008-05-01. PMID:18234696. the estimated rate of lesion growth over 20 years was 0.80 cm3/year in those who retained a relapsing remitting multiple sclerosis course, and 2.89 cm3/year in those who developed secondary progressive multiple sclerosis, a difference of 2.09 cm3/year (95% ci: 0.77, 2.96; p < 0.001). 2008-05-01 2023-08-12 human
Lars Vedel Kessing, Mette Harhoff, Per Kragh Anderse. Increased rate of treatment with antidepressants in patients with multiple sclerosis. International clinical psychopharmacology. vol 23. issue 1. 2008-02-14. PMID:18090509. patients with a diagnosis of multiple sclerosis had a 3.21 [95% confidence intervals (ci): 2.56-4.03] times increased rate of subsequently purchasing antidepressants compared with patients with a first diagnosis of osteoarthritis, and a 4.75 times (95% ci: 3.91-5.76) increased rate when compared with the rate among a gender-matched, age-matched, and calendar-matched sample of the general population. 2008-02-14 2023-08-12 Not clear
Yann Mikaeloff, Guillaume Caridade, Béatrice Husson, Samy Suissa, Marc Tardie. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 11. issue 2. 2007-06-01. PMID:17188007. an increased risk of relapse was associated with optic neuritis (hazard ratio, 5.23; 95% ci, 2-13.65), familial history of central nervous system inflammatory demyelination (7.79; 1.54-39.5), barkhof multiple sclerosis (ms) criteria on mri (2.52; 1.04-6.12) and no neurological sequelae after first attack (3.79; 1.12-12.85). 2007-06-01 2023-08-12 Not clear
H Tremlett, S Seemüller, Y Zhao, E M Yoshida, J D en M Oger, J Petka. Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients. Neurology. vol 67. issue 7. 2006-11-08. PMID:17030771. the risk of an abnormal liver test in 813 patients with multiple sclerosis or clinically isolated syndrome enrolled in placebo arms of clinical trials was greater than expected for alanine aminotransferase (alt) (relative risk [rr] 3.7; 95% ci: 2.3 to 6.0) and aspartate aminotransferase (ast) (rr 2.2; 95% ci: 1.3 to 3.6), although not alkaline phosphatase (ap) or total bilirubin, at first presentation. 2006-11-08 2023-08-12 Not clear
Christopher McGuigan, Ciaran Dunne, John Crowley, Richard Hagan, Genevieve Rooney, Eimear Lawlor, Michael Hutchinso. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. Journal of neurology. vol 252. issue 10. 2006-02-06. PMID:16158194. a recent epidemiological study of multiple sclerosis in county donegal in the northwest of ireland and county wexford in the southeast found a significant prevalence difference of 63.9/100,000 (95% ci 49.3-82.7/100,000) between the two regions (z = 3.94, p 2006-02-06 2023-08-12 Not clear
P Cabre, A Signate, S Olindo, H Merle, D Caparros-Lefebvre, O Béra, D Smadj. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain : a journal of neurology. vol 128. issue Pt 12. 2006-01-26. PMID:16183661. the crude prevalence of multiple sclerosis was 14.8/10(5) on december 31, 1999 (95% ci: 11.9-17.7); and its crude mean annual incidence for the period july 1, 1999 to june 30, 2002 was 1.4/10(5) (95% ci: 1.0-1.8), confirming its emergence in the french west indies. 2006-01-26 2023-08-12 human
David A Geier, Mark R Geie. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. vol 38. issue 4. 2005-11-01. PMID:16206512. adults receiving hbv had significantly increased odds ratios (or) for multiple sclerosis (or = 5.2, p < 0.0003, 95% confidence interval (ci) = 1.9 - 20), optic neuritis (or = 14, p < 0.0002, 95% ci = 2.3 - 560), vasculitis (or = 2.6, p < 0.04, 95% ci = 1.03 - 8.7), arthritis (or = 2.01, p < 0.0003, 95% ci = 1.3 - 3.1), alopecia (or = 7.2, p < 0.0001, 95% ci = 3.2 - 20), lupus erythematosus (or = 9.1, p < 0.0001, 95% ci = 2.3 - 76), rheumatoid arthritis (or = 18, p < 0.0001, 95% ci = 3.1 - 740), and thrombocytopenia (or = 2.3, p < 0.04, 95% ci = 1.02 - 6.2) in comparison to the tcv group. 2005-11-01 2023-08-12 Not clear
Miguel A Hernán, Susan S Jick, Giancarlo Logroscino, Michael J Olek, Alberto Ascherio, Hershel Jic. Cigarette smoking and the progression of multiple sclerosis. Brain : a journal of neurology. vol 128. issue Pt 6. 2005-09-13. PMID:15758034. the odds ratio [95% confidence interval (ci)] of multiple sclerosis was 1.3 (1.0-1.7) for ever smokers compared with never smokers. 2005-09-13 2023-08-12 Not clear